Granite Investment Partners LLC Buys New Shares in Option Care Health, Inc. (NASDAQ:OPCH)

Granite Investment Partners LLC bought a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 303,956 shares of the company's stock, valued at approximately $7,052,000. Granite Investment Partners LLC owned 0.18% of Option Care Health at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Sterling Capital Management LLC lifted its position in shares of Option Care Health by 638.5% during the fourth quarter. Sterling Capital Management LLC now owns 2,954 shares of the company's stock worth $69,000 after purchasing an additional 2,554 shares during the last quarter. Whetstone Capital Advisors LLC purchased a new stake in Option Care Health in the 4th quarter valued at about $815,000. Raymond James Financial Inc. bought a new position in Option Care Health in the 4th quarter worth about $2,027,000. Renaissance Technologies LLC raised its stake in shares of Option Care Health by 2,032.6% during the fourth quarter. Renaissance Technologies LLC now owns 330,546 shares of the company's stock valued at $7,669,000 after acquiring an additional 315,046 shares in the last quarter. Finally, Bank of Nova Scotia bought a new position in Option Care Health in the fourth quarter worth approximately $228,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

OPCH has been the subject of several research reports. JMP Securities reiterated a "market outperform" rating and issued a $30.00 target price (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and raised their target price for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Barrington Research upped their price target on shares of Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a research report on Thursday, February 27th. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their price objective for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, JPMorgan Chase & Co. upped their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $33.00.

Insider Activity at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Stock Down 0.6 %

Shares of OPCH stock traded down $0.19 during trading hours on Friday, reaching $32.09. 1,835,227 shares of the company's stock were exchanged, compared to its average volume of 1,795,081. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The stock's 50 day moving average is $33.32 and its 200-day moving average is $28.64. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company has a market cap of $5.27 billion, a price-to-earnings ratio of 26.96, a P/E/G ratio of 2.30 and a beta of 1.07.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.